Neurotrophic Keratitis - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Neurotrophic Keratitis Market is accounted for $60.56 million in 2018 and is expected to reach $279.06 million by 2027 growing at a CAGR of 18.5% during the forecast period. Rising reported cases and surge in investments in research and clinical study and product approvals are the major factors propelling the market growth. However, high cost of treatment is hampering the market growth.
Neurotrophic keratitis is anorphan disease which is mainly caused by the damage of the fifth cranial nerve from thetrigeminal nucleus to the nerve endings present in the eye corneal region.The treatment method is implemented as per the different stages of the disease.
Based on the treatment, the drugs segment is going to have a lucrative growth during the forecast period as artificial tears are prescribed for all the stages due to its ability to provide wetness and lubrication to the corneal surface and ensure cleanliness. By geography, North America is going to have a lucrative growth during the forecast period owing to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, and presence of key players.
Some of the key players profiled in the Neurotrophic Keratitis Market include Walgreens, ReGenTree, LLC, Novartis AG, Dompefarmaceutici S.p.A., CooperVision, Bayer AG, Bausch & Lomb Incorporated, Allergan, Plc., Abbott Laboratories, Inc. and Johnson & Johnson.
• Surgical Intervention
• Stage I
• Stage II
• Stage III
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.